Yellow Fever Treatment Market to Surpass US$ 607.6 Million by 2028, Says Coherent Market Insights (CMI)

Pune, INDIA


SEATTLE, Nov. 22, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global yellow fever treatment market is estimated to be valued at US$ 470.5 million in 2021 and is expected to exhibit a CAGR of 3.7% during the forecast period (2021-2028).

Key Trends and Analysis of the Global Yellow Fever Treatment Market:

Key trends in the market include the launch of research projects, which is expected to drive the global yellow fever treatment market growth over the forecast period. For instance, in August 2021, USF researchers launched a smartphone app that is believed to automatically identify disease-carrying species such as Aedes aegypti, a known transmitter of Zika, dengue, and yellow fever. With the help of this app, a robust image database can be built that identifies mosquitoes and monitors their habitat by using an integrative approach. The mosquito images, along with details about their habitat, are essential to training the AI’s algorithm, which categorizes the anatomical components of the insect and matches them with the known characteristics of Aedes aegypti.

Request for Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4774
Key Market Takeaways:

The global yellow fever treatment market is expected to exhibit a CAGR of 3.7% during the forecast period. The increasing funds and support from various organizations for research and development of new drugs for yellow fever are expected to drive the yellow fever treatment market over the forecast period. For instance, in September 2018, BioCryst Pharmaceuticals, Inc. have announced that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, had awarded BioCryst an additional US$ 3.5 million to support clinical trials of galidesivir, an adenosine analog, broad spectrum antiviral drug in patients with yellow fever.

On the basis of application, the hospital segment is expected to account for a major share of the global yellow fever vaccine market by 2031 due to easy access for outpatient department (OPD) patients to buy medicines.

Competitive Landscape:

Key players operating in the global yellow fever treatment market include Sanofi Pasteur SA, Janssen, Pfizer Inc., BIOCRYST PHARMACEUTICALS, INC., Tychan Pte. Ltd., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Bayer AG, GlaxoSmithKline plc, Bio-Manguinhos, Institut Pasteur de Dakar, and FSUE Chumakov

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4774

Market Segmentation:

  • Global Yellow Fever Treatment Market, By Transmission Type:
    • Sylvatic Yellow Fever
    • Intermediate Yellow Fever
    • Urban Yellow Fever
  • Global Yellow Fever Treatment Market, By Treatment Type:
    • Vaccines
    • Medications
    • Others
  • Global Yellow Fever Treatment Market, By Application:
    • Hospitals
    • Clinics
    • Community Health Centres
    • Others
  • Global Yellow Fever Treatment Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa

Related Market Intelligence Reports:

Anti-malarial Drugs Market, by Drug Class (Aminoquinolines, Quinoline-methanol (4-quinolinemethanols), Cinchona Alkaloids, Biguanides, Sulfonamides and Sulfones, and Others), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Hydroxychloroquine Market, By Disease Indication (Malaria, Coronavirus Disease, Lupus Erythematosus, and Rheumatoid Arthritis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027


About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

Follow Us: LinkedInTwitter

 

Coordonnées